Regulation of glycogen synthase kinase-3 in patients with affective disorders

Biol Psychiatry. 2007 Jan 15;61(2):139-41. doi: 10.1016/j.biopsych.2006.11.008.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • Antimanic Agents / pharmacology
  • Bipolar Disorder / physiopathology*
  • Depressive Disorder, Major / physiopathology*
  • Glycogen Synthase Kinase 3 / antagonists & inhibitors
  • Glycogen Synthase Kinase 3 / metabolism*
  • Glycogen Synthase Kinase 3 beta
  • Humans
  • Lithium Carbonate / pharmacology
  • Mice
  • Microfilament Proteins
  • Prefrontal Cortex / physiopathology
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Treatment Outcome
  • Vesicular Transport Proteins / metabolism

Substances

  • Antimanic Agents
  • CCDC88A protein, human
  • Microfilament Proteins
  • Vesicular Transport Proteins
  • Lithium Carbonate
  • Glycogen Synthase Kinase 3 beta
  • Glycogen Synthase Kinase 3